BONUS BIOGROUP
Bonus BioGroup (TASE: BONS) is a product-focused biotechnology company applying proprietary, innovative technology to supply tissue-regenerating viable bone grafts. It is a pioneer in developing cell therapy and tissue engineering products based on autologous bone implants that enable efficient bone transplantation and provide cell-based bone replacement for repairing bone lesions. Bonus BioGroup developed a novel method to grow unique 3D high-density bone grafts, based on multi-cell 3D cultures. This leads to bone implants which are available on demand, personalized to each patient, safer, cost-effective, and more efficient than any other solution available to date.
BONUS BIOGROUP
Industry:
Biotechnology Health Care
Founded:
2008-01-01
Address:
Haifa, Hefa, Israel
Country:
Israel
Website Url:
http://www.bonus-bio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving
Stock Details
Official Site Inspections
http://www.bonus-bio.com Semrush global rank: 7.34 M Semrush visits lastest month: 516
- Host name: ampro2.fcomet.com
- IP address: 172.105.70.171
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Bonus BioGroup"
About Us - Bonus BioGroup LTD
Bonus Biogroup's journey to the present day is a testament to its unwavering ambition and commitment to revolutionizing regenerative medicine. The company's patient-centric approach, scientific leadership, and technological โฆSee details»
Leadership - Bonus BioGroup LTD
Ms. Assays is the General Manager of SISMA (www2.sisma.org.il), a non-profit educational organization, and a former member of the National Petroleum Council, Ministry of Energy, โฆSee details»
Bonus BioGroup - Crunchbase Company Profile & Funding
Bonus BioGroup (TASE: BONS) is a product-focused biotechnology company applying proprietary, innovative technology to supply tissue-regenerating viable bone grafts. It is a โฆSee details»
Bonus Biogroup - LinkedIn
Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company engaged in the R&D of tissue-engineered and cell therapy products. Bonus CEO Dr. Shai Meretzki, one of Israel's most ...See details»
Bonus BioGroup Ltd. (BBIXF) Company Profile & Facts - Yahoo โฆ
See the company profile for Bonus BioGroup Ltd. (BBIXF) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Bonus BioGroup Company Description - Stock Analysis
Nov 19, 2024 Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The companyโs products in development include โฆSee details»
Bonus BioGroup - Foreign Startup | Startup Nation Finder
May 16, 2022 Bonus BioGroup is a product-focused biotechnology company applying proprietary technology to supply tissue-regenerating, viable bone grafts. The company develops cell therapy and tissue-engineering products based on โฆSee details»
Bonus BioGroup Company Profile | Management and Employees โฆ
Bonus BioGroup Profile and History Since its establishment, Bonus BioGroup has worked to develop cell therapies and tissue-engineered products for bone regeneration. The main โฆSee details»
Press room - Bonus BioGroup LTD
Bonus Biogroup is pleased to announce that the Japan Patent Office has granted a patent providing Bonus Therapeutics, a wholly-owned subsidiary of the Company, exclusive rights to โฆSee details»
Bonus BioGroup Receives Approval to Expand Phase-II Clinical โฆ
TEL AVIV, ISRAEL, Aug. 22, 2021 (GLOBE NEWSWIRE) -- Bonus BioGroup LTD or "the Company" (BONS.TA), an Israeli clinical-stage biotechnology company, has received official โฆSee details»
Bonus BioGroup Ltd. (BBIXF) Company Profile & Overview - Stock โฆ
Aug 22, 2024 Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The companyโs products in development include โฆSee details»
Bonus BioGroup Ltd, BONS:TLV summary - FT.com - Financial Times
Nov 14, 2024 Bonus Biogroup Ltd, formerly Oceana Advanced Industries Ltd, is an Israel-based product-focused biotechnology company applying technology for supplying bone regeneration โฆSee details»
Bonus BioGroup - Facebook
Matam Advanced Technology Park, Haifa, Israel, 31905. Address. +972 73-206-7154See details»
Press Room 2023 - Bonus BioGroup LTD
Bonus Biogroup's Bioinformatics Unit presents its first achievements at the Paris 2023 annual meeting of the International Society for Cell and Gene Therapy (ISCT), highlighting โฆSee details»
Bonus BioGroup Reports Resounding Success in Phase-I Clinical โฆ
Jul 20, 2021 TEL AVIV, ISRAEL / ACCESSWIRE / July 19, 2021 / Bonus BioGroup LTD (TASE:BONS), an Israeli clinical-stage biotechnology company, announced further โฆSee details»
Press Room - bonus-bio.com
Oct 30, 2024 Additionally, the MOH issued a certificate of accreditation confirming that the industrial production facilities for each of the two products, BonoFill and MesenCure, located at โฆSee details»
Bonus BioGroup Reports 94% Survival Rate for Severe COVID-19 โฆ
Dec 2, 2021 Tel Aviv, Israel--(Newsfile Corp. - December 2, 2021) - Bonus BioGroup or (TASE: BONS) "the Company", a clinical-stage Israeli biotechnology company engaged in the โฆSee details»
Investors' presentation - Bonus BioGroup LTD
Embrace the Bonus Biogroup Advantage and join us on our journey to become a global frontrunner in next-generation cell therapy and tissue engineering. Take this opportunity to be โฆSee details»
Bonus BioGroup Ltd. (BONS.TA) - Yahoo Finance
Find the latest Bonus BioGroup Ltd. (BONS.TA) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»